Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.

Hamster to rat cardiac xenografts undergo delayed rejection as compared with the hyperacute rejection of discordant xenografts. Elicited xenoreactive Abs (EXA) are thought to initiate hamster to rat cardiac xenograft rejection. In this study, we demonstrate that following transplantation of a hamster heart, rats generated high levels of EXA. Adoptive transfer into naive recipients of purified IgM, IgG2b, or IgG2c, but not IgG1 or IgG2a EXA, induced xenograft rejection in a complement-dependent manner. Ability of EXA to cause rejection correlated with complement activation, platelet aggregation, and P-selectin expression in the xenograft endothelium. Cyclosporin A (CyA) administration, after transplantation, totally suppressed IgG1, IgG2a, IgG2b, and IgG2c EXA, and inhibited IgM EXA production, but failed to overcome rejection. Administration of cobra venom factor (CVF), 1 day before and at the time of transplantation, resulted in complement inhibition during 3 days after transplantation, which failed to overcome rejection. Combination of CyA and CVF, which we have previously shown to overcome rejection, resulted in suppression of IgG EXA production and in the return of IgM XNA to preimmunization serum levels, 3 to 7 days after xenotransplantation, while complement remained inhibited. Thus, under CyA/CVF treatment, complement activation by hamster cells was suppressed following xenotransplantation, and presumably for this reason xenograft rejection did not occur. In conclusion, our data demonstrate that EXA play a pivotal role in the pathogenesis of xenograft rejection and that CyA and CVF suppress xenograft rejection by preventing exposure of xenograft endothelial cells to complement activation by EXA.

[1]  C. Ferran,et al.  Protective genes expressed in endothelial cells: a regulatory response to injury. , 1997, Immunology today.

[2]  M. Waer,et al.  Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. , 1997, Journal of immunology.

[3]  A. Mantovani,et al.  The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity , 1997, The Journal of experimental medicine.

[4]  A. Mantovani,et al.  Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.

[5]  W. Baldwin,et al.  Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. , 1997, Transplantation.

[6]  D. Candinas,et al.  Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment , 1997, Nature Medicine.

[7]  C. Ferran,et al.  A20 expression inhibits endothelial cell activation. , 1997, Transplantation Proceedings.

[8]  A. Scheffold,et al.  P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues , 1997, Nature.

[9]  C. Ferran,et al.  Delayed xenograft rejection. , 1996, World journal of surgery.

[10]  H. Bazin,et al.  Use of Anti-μ Monoclonal Antibodies in Xenotransplantation: A Potential Approach To Overcome Vascular Rejection , 1997 .

[11]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[12]  J. Platt,et al.  Transplantation of discordant xenografts: a challenge revisited. , 1996, Immunology today.

[13]  D. Alexander,et al.  Protein tyrosine phosphatases in T-cell development, apoptosis and signalling. , 1996, Immunology today.

[14]  Bradley Ja,et al.  Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass. , 1996 .

[15]  A. Weyrich,et al.  Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.

[16]  H. Bazin,et al.  Modulation of rat B cell differentiation in vivo by the administration of an anti-mu monoclonal antibody. , 1996, Journal of immunology.

[17]  R. Oriol,et al.  Genetic control of the humoral immune response to xenografts. I. Functional characterization of rat monoclonal antibodies to hamster heart xenografts. , 1995, Transplantation.

[18]  D. Cramer,et al.  Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes. , 1995, Transplantation.

[19]  B. Cronstein,et al.  Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[21]  R. Dell,et al.  Guidelines for xenotransplantation. , 1995, Science.

[22]  F. Podlaski,et al.  Interleukin‐12 profoundly up‐regulates the synthesis of antigen‐specific complement‐fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo , 1995, European journal of immunology.

[23]  A. Dalmasso,et al.  Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. , 1994, Transplantation.

[24]  K. Stuhlmeier,et al.  Selective inhibition of E‐selectin, ICAM‐1, and VCAM in endothelial cells , 1994, European journal of immunology.

[25]  H. Izutani,et al.  Analysis of rejection mechanism in the rat to mouse cardiac xenotransplantation. Role and characteristics of anti-endothelial cell antibodies. , 1994, Transplantation.

[26]  A. Dalmasso,et al.  The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in nonhuman primates. , 1994, Transplantation.

[27]  F. Bach,et al.  In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody. , 1993, Transplantation.

[28]  W. Hancock,et al.  In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. , 1993, Transplantation proceedings.

[29]  J. Wallwork,et al.  EVIDENCE THAT LONG‐TERM SURVIVAL OF CONCORDANT XENOGRAFTS IS ACHIEVED BY INHIBITION OF ANTISPECIES ANTIBODY PRODUCTION , 1992, Transplantation.

[30]  C. Snapper,et al.  Induction of IgG3 secretion by interferon gamma: a model for T cell- independent class switching in response to T cell-independent type 2 antigens , 1992, The Journal of experimental medicine.

[31]  J. Platt,et al.  Accommodation: a working paradigm for progressing toward clinical discordant xenografting. , 1991, Transplantation proceedings.

[32]  H. Bazin,et al.  Rat (and mouse) monoclonal antibodies. VIII. ELISA measurement of Ig production in mouse hybridoma culture supernatants. , 1990, Journal of immunological methods.

[33]  R. Coffman,et al.  Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.

[34]  B. Morgan.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[35]  M. Brüggemann,et al.  A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions mu, gamma 1, gamma 2a, gamma 2b, gamma 2c, epsilon, and alpha. , 1989, Journal of immunology.

[36]  J. Squifflet,et al.  Present experiences in a series of 26 ABO-incompatible living donor renal allografts. , 1987, Transplantation proceedings.

[37]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[38]  H. Bazin,et al.  Rat (and mouse) monoclonal antibodies. V. A simple automated technique of antigen purification by immunoaffinity chromatography. , 1986, Journal of immunological methods.

[39]  J. Slack,et al.  Subclass restriction of murine antibodies. V. The IgG plaque-forming cell response to thymus-independent and thymus-dependent antigens in athymic and euthymic mice. , 1982, Cellular immunology.

[40]  Davie,et al.  Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats , 1980, The Journal of experimental medicine.

[41]  H. Bazin,et al.  Allotypes of rat immunoglobulins. II. Distribution of the allotypes of kappa and alpha chain loci in different inbred strains of rats. , 1974, Immunochemistry.

[42]  H. Bazin,et al.  Allotypes of Rat Immunoglobulins: I. An Allotype at the α-Chain Locus , 1974 .